Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000450 · ClinicalTrials.gov registry record · Phase 4
Naltrexone Maintenance Treatment of Alcoholism
A Phase 4 study, sponsored by The Scripps Research Institute.
- Completed
- Registry status
- Phase 4
- Development phase
- 159
- Enrollment target
NCT00000450: Completed Phase 4 study, sponsored by The Scripps Research Institute.
NCT00000450 is a Phase 4 study that has completed, run by The Scripps Research Institute. The registered enrollment target is 159 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (69% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000450, a Phase 4 study, has completed, sponsored by The Scripps Research Institute.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 159 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the long-term effectiveness of naltrexone treatment in alcohol-dependent patients who respond to short-term treatment. Those who respond to short-term treatment will be randomized to a 1-year, double-blind, placebo-controlled maintenance phase with a 6-month posttreatment followup.
Interventions
- DRUG Naltrexone Tablet
- DRUG Matched Placebo Tablet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 159 participants |
| Start Date | 1997-04-10 |
| Est. Completion | 2002-02-13 |
| Phase | Phase 4 |
What the finished NCT00000450 record still lists
NCT00000450 is an interventional study that assigns participants to a tested intervention. The registered 159 participants enrollment target is mid-sized for trials with a published cap, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (69% lower).
The record links to 0 conditions, and to 2 interventions - of which Naltrexone Tablet is the first listed.
NCT00000450 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00000450 about?
NCT00000450 is a clinical study titled "Naltrexone Maintenance Treatment of Alcoholism". The purpose of this study is to determine the long-term effectiveness of naltrexone treatment in alcohol-dependent patients who respond to short-term treatment. Those who respond to short-term treatment will be randomized to a 1-year, double-blind, placebo-controlled maintenance phase with a 6-month...
What is the current status of trial NCT00000450?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 159 participants. The study started on 1997-04-10. Estimated completion is 2002-02-13.
What interventions are being tested in trial NCT00000450?
The interventions under investigation include: Naltrexone Tablet (DRUG), Matched Placebo Tablet (DRUG).
Who is sponsoring clinical trial NCT00000450?
This trial is sponsored by The Scripps Research Institute, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00000450's enrollment target sits among peer trials
159 516th of 2000 higher than 1,485 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05267626 · 159 participants · Phase 1
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
- NCT06321575 · 159 participants · NA
The Golazo® Peripheral Atherectomy System for a Safe and Effective Atherectomy (GREAT Trial)
- NCT06729151 · 159 participants
Effect of Intradetrusor onabotulinumtoxinA Injection Versus Conservative Management on Female Sexual Function in Patients With Bladder Pain Syndrome
- NCT07023731 · 159 participants · Phase 1
A Study to Evaluate ARV-806 in Adults With Advanced Cancer That Has the KRAS G12D Mutation
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI